U.S. flag

An official website of the United States government

GRCh37/hg19 2p16.3(chr2:51193858-51433041)x1 AND not provided

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 14, 2020
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001829173.1

Allele description [Variation Report for GRCh37/hg19 2p16.3(chr2:51193858-51433041)x1]

GRCh37/hg19 2p16.3(chr2:51193858-51433041)x1

Gene:
NRXN1:neurexin 1 [Gene - OMIM - HGNC]
Variant type:
copy number loss
Cytogenetic location:
2p16.3
Genomic location:
Chr2: 51193858 - 51433041 (on Assembly GRCh37)
Preferred name:
GRCh37/hg19 2p16.3(chr2:51193858-51433041)x1
HGVS:
NC_000002.11:g.(?_51193858)_(51433041_?)del

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002095713Quest Diagnostics Nichols Institute San Juan Capistrano
no assertion criteria provided
Pathogenic
(Oct 14, 2020)
germlineclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Quest Diagnostics Nichols Institute San Juan Capistrano, SCV002095713.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This deletion interval involves the 5' portion of NRXN1 (OMIM *600565) gene. Biallelic variation of NRXN1 can cause autosomal recessive Pitt-Hopkins-like syndrome-2 (OMIM 614325). Additionally, heterozygous deletion of NRXN1 has been reported in patients with a wide spectrum of developmental and neuropsychiatric disorders, including intellectual disability, autism spectrum disorders, hypotonia and epilepsy, and disorders of speech and verbal expression. While some deletions occurred de novo/segregated with disease in families, others were inherited from asymptomatic parents, suggesting reduced penetrance and variable expressivity (see list of references at bottom). Despite this, and the occurrence of NRXN1 deletions in the general populations of the Database of Genomic Variants, a recent study suggests partial deletions near the 5' end (like the one identified here) have a higher penetrance for expression of neurodevelopmental phenotypes compared to those at the 3' end (Lowther et al. Genet Med. 2017 Jan;19(1):53-61. PMID: 27195815). Thus, the clinical significance of this copy number variant (CNV) is pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 11, 2022